Abstract
Introduction: Following the British Medical Research Council’s guidance on how to develop and evaluate complex interventions, the occupational therapy program (ABLE) was developed to focus on enhancing ability to perform activities of daily living (ADL) tasks among persons living with chronic conditions. ABLE is a structured eight-week generic homebased adaptational program, including five-eight individualised sessions. Feasibility in terms of content and delivery has been established.
Objectives: To evaluate the effectiveness of ABLE compared to usual occupational therapy. It is hypothesised, that participants receiving ABLE will achieve a significantly higher ADL ability at end of intervention and 6-months follow-up.
Method: Participants are randomised and allocated to either ABLE or usual occupational therapy. Co-primary outcomes are self-reported ADL ability (ADL-Interview (ADL-I) performance) and observed ADL motor ability (Assessment of Motor and Process Skills (AMPS)). Secondary outcomes are perceived satisfaction with ADL task performance (ADL-I satisfaction); and observed ADL process ability (AMPS). Outcomes will be analysed on an intention-to-treat (ITT) basis, with last observation carried forward. Superiority will be determined if participants in the ABLE group will improve >0.30 logits on the AMPS ADL motor scale, and >0.64 logits on the ADL-I performance scale, compared to the usual occupational therapy group.
Results: Data will be analysed autumn 2021 and inform about participants´ characteristics and differences between groups using primary, secondary and explorative outcomes analysed for statistical significance and clinical relevance.
Conclusion: It will be concluded if the ABLE program is efficient and ready to be implemented in clinical practice.
Objectives: To evaluate the effectiveness of ABLE compared to usual occupational therapy. It is hypothesised, that participants receiving ABLE will achieve a significantly higher ADL ability at end of intervention and 6-months follow-up.
Method: Participants are randomised and allocated to either ABLE or usual occupational therapy. Co-primary outcomes are self-reported ADL ability (ADL-Interview (ADL-I) performance) and observed ADL motor ability (Assessment of Motor and Process Skills (AMPS)). Secondary outcomes are perceived satisfaction with ADL task performance (ADL-I satisfaction); and observed ADL process ability (AMPS). Outcomes will be analysed on an intention-to-treat (ITT) basis, with last observation carried forward. Superiority will be determined if participants in the ABLE group will improve >0.30 logits on the AMPS ADL motor scale, and >0.64 logits on the ADL-I performance scale, compared to the usual occupational therapy group.
Results: Data will be analysed autumn 2021 and inform about participants´ characteristics and differences between groups using primary, secondary and explorative outcomes analysed for statistical significance and clinical relevance.
Conclusion: It will be concluded if the ABLE program is efficient and ready to be implemented in clinical practice.
| Originalsprog | Engelsk |
|---|---|
| Publikationsdato | 28 aug. 2022 |
| Status | Udgivet - 28 aug. 2022 |
| Begivenhed | World Federation of Occupational Therapists (WFOT) Congress 2022: Occupational R-Evolution - Le Paris Convention Centre, Paris, Frankrig Varighed: 28 aug. 2022 → 31 aug. 2022 Konferencens nummer: 18 https://wfotcongress2022.org/ |
Konference
| Konference | World Federation of Occupational Therapists (WFOT) Congress 2022 |
|---|---|
| Nummer | 18 |
| Lokation | Le Paris Convention Centre |
| Land/Område | Frankrig |
| By | Paris |
| Periode | 28/08/22 → 31/08/22 |
| Internetadresse |